Abstract
The biomedical research sciences are currently facing a challenge highlighted in several recent publications: concerns about the rigor and reproducibility of studies published in the scientific literature.Research progress is strongly dependent on published work. Basic science researchers build on their own prior work and the published findings of other researchers. This work becomes the foundation for preclinical and clinical research aimed at developing innovative new diagnostic tools and disease therapies. At each of the stages of research, scientific rigor and reproducibility are critical, and the financial and ethical stakes rise as drug development research moves through these stages. This article is protected by copyright. All rights reserved.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
